Olfactory threshold (OT), which is associated with short-term inflammatory activity in relapsing MS, serves as an independent predictor of freedom from disease activity after starting disease modifying therapy (DMT), according...
For patients with MS who received the COVID-19 vaccine, clinical disease worsening was uncommon and primarily related to symptom recurrence rather than new relapses, according to results published in Neurology Clinical Practice....